Speaker illustration

Associate Professor Chiara Melloni

Quintiles Transnational Corp., Durham (United States of America)

Efficacy and safety of apixaban versus warfarin in patients with atrial fibrillation and active cancer: insights from the ARISTOTLE trial

Event: ESC Congress 2016

Topic: Atrial fibrillation (AF)

Session: New trends in antithrombotic therapy for atrial fibrillation


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb